The tale of the long tail: the cytoplasmic domain of HIV-1 gp41.
about
Structural and functional comparisons of retroviral envelope protein C-terminal domains: still much to learnUnderstanding the process of envelope glycoprotein incorporation into virions in simian and feline immunodeficiency virusesThe role of matrix in HIV-1 envelope glycoprotein incorporationDeconstructing the Antiviral Neutralizing-Antibody Response: Implications for Vaccine Development and ImmunityComputational prediction of broadly neutralizing HIV-1 antibody epitopes from neutralization activity dataDifferences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder ViruscellPACK: a virtual mesoscope to model and visualize structural systems biology.Retromer regulates HIV-1 envelope glycoprotein trafficking and incorporation into virions.Human Ubc9 is involved in intracellular HIV-1 Env stability after trafficking out of the trans-Golgi network in a Gag dependent manner.Comparison of the specificities of IgG, IgG-subclass, IgA and IgM reactivities in African and European HIV-infected individuals with an HIV-1 clade C proteome-based arrayPre-clinical development of a recombinant, replication-competent adenovirus serotype 4 vector vaccine expressing HIV-1 envelope 1086 clade C.Systematic analysis of intracellular trafficking motifs located within the cytoplasmic domain of simian immunodeficiency virus glycoprotein gp41HIV-1 Tropism Determines Different Mutation Profiles in Proviral DNA.CATNAP: a tool to compile, analyze and tally neutralizing antibody panelsEnvelope Glycoprotein Internalization Protects Human and Simian Immunodeficiency Virus-Infected Cells from Antibody-Dependent Cell-Mediated Cytotoxicity.Elite Control, Gut CD4 T Cell Sparing, and Enhanced Mucosal T Cell Responses in Macaca nemestrina Infected by a Simian Immunodeficiency Virus Lacking a gp41 Trafficking Motif.Morphology and ultrastructure of retrovirus particles.The Envelope Cytoplasmic Tail of HIV-1 Subtype C Contributes to Poor Replication Capacity through Low Viral Infectivity and Cell-to-Cell TransmissionIncreased infectivity in human cells and resistance to antibody-mediated neutralization by truncation of the SIV gp41 cytoplasmic tailThe frantic play of the concealed HIV envelope cytoplasmic tail.Membrane structure correlates to function of LLP2 on the cytoplasmic tail of HIV-1 gp41 protein.Global rescue of defects in HIV-1 envelope glycoprotein incorporation: implications for matrix structure.Single Amino Acid Substitution N659D in HIV-2 Envelope Glycoprotein (Env) Impairs Viral Release and Hampers BST-2 Antagonism.The Glycoprotein B Cytoplasmic Domain Lysine Cluster Is Critical for Varicella-Zoster Virus Cell-Cell Fusion Regulation and InfectionAntigenic properties of the HIV envelope on virions in solution.Unique functional properties of conserved arginine residues in the lentivirus lytic peptide domains of the C-terminal tail of HIV-1 gp41.The most important thing is the tail: multitudinous functionalities of intrinsically disordered protein termini.Molecular events accompanying rous sarcoma virus rescue from rodent cells and the role of viral gene complementation.Envelope Glycoprotein Trimers as HIV-1 Vaccine ImmunogensDense Array of Spikes on HIV-1 Virion Particles.Less is more: Ebola virus surface glycoprotein expression levels regulate virus production and infectivityRetroviral host range extension is coupled with Env-activating mutations resulting in receptor-independent entry.A heterologous prime-boosting strategy with replicating Vaccinia virus vectors and plant-produced HIV-1 Gag/dgp41 virus-like particles.HIV-1 Cell-Free and Cell-to-Cell Infections Are Differentially Regulated by Distinct Determinants in the Env gp41 Cytoplasmic Tail.HIV-1 ENVELOPE. Effect of the cytoplasmic domain on antigenic characteristics of HIV-1 envelope glycoprotein.The V4 and V5 Variable Loops of HIV-1 Envelope Glycoprotein Are Tolerant to Insertion of Green Fluorescent Protein and Are Useful Targets for Labeling.Truncating the Gp41 Cytoplasmic Tail of SIV Decreases Sensitivity to Neutralizing Antibodies without Increasing Envelope Content of Virions.Efficient Fusion at Neutral pH by Human Immunodeficiency Virus gp41 Trimers containing the Fusion Peptide and Transmembrane Domain.Reassessment of the capacity of the HIV-1 Env cytoplasmic domain to trigger NF-κB activation.HIV-1 adaptation studies reveal a novel Env-mediated homeostasis mechanism for evading lethal hypermutation by APOBEC3G.
P2860
Q26862369-60ACB81F-5BB9-41CA-A041-61DDC0F1F0AAQ27021655-5F8EE1C2-2810-4DBC-BF3A-E27699064AD7Q27023106-5A997E85-EDB2-4EFF-90C7-D6AC8C182F70Q27654848-9D368F06-9E0F-428A-BA58-87F5185BEA18Q28535583-68505A5F-B28F-4EA9-BBD9-374D5EDF99D3Q28551914-097B63F5-1F08-4B1F-95A0-678188E278AEQ30612366-2A30B27A-DF19-40E7-9773-63468F18BB16Q34506932-113CAC82-5857-4FDD-A13F-9EEC0BD372D8Q34828531-2E18F846-F5B5-4349-8868-657B3C26C3A2Q35057791-747B65A6-4B25-461B-8A21-3AE781B413D4Q35061529-DC58F56F-E721-49BC-AB88-AC56F9BFFFBBQ35494155-B6D55FAD-5E43-4F59-BCF3-2041F49BC517Q35790224-0D81B4F6-4404-483B-8AA9-9C7D3F0A6C97Q35810109-602D4B79-5DB0-4EBD-B819-CEE4C5046BB7Q36086204-B2D879B7-C8AE-4DC5-AD3E-111C6DF0C16CQ36086229-B4A2C829-33C5-438A-AF13-847DD2B69E2DQ36121053-FDE0A24C-FD1E-4AB5-A402-726575C723D0Q36123960-6D8CA40E-F385-40AD-B1E8-28976FAD53ECQ36841032-D7244182-2234-4D1B-9AC9-8B1A8BBF7D2FQ36940646-846573D7-D56B-4E23-AA83-33AAAD2A490BQ37078294-53FC36F1-B561-4085-B646-B4A796E15623Q37308716-7B4F1705-13B1-4146-8FA4-6A175B46513CQ37378819-AD1E6C69-EE7C-4BE8-8442-3E801ABDD0D0Q37512919-8A64776B-2CC9-4D1F-8FB1-BE5791823B79Q37547245-C1C4CEA6-2186-4F29-B0A7-1F04A6594FCBQ37635804-EC9EFA4D-D074-4B73-AB9E-25DF6C17D7D5Q38105815-0C6A2EF8-4A38-4B71-B967-B6CFD2EA5AFFQ38326833-F5496E72-9D91-4A97-8A29-03BFA9FDFD67Q38581943-6F89A087-1616-4E77-8197-75DA4BBF119DQ38817990-E7F6B989-D220-4F71-BFAE-FEFBE47742DAQ38940832-EE547F48-D33B-459B-95E2-164597ACCFA3Q40162632-6D25E2E4-177E-4AD7-9BBF-7809DD266DA5Q40220988-3C17FD10-8D81-41C6-9FCD-0251CCE3D549Q41127118-C2E590BA-EAFA-4CFC-89D9-465A2150D6D1Q41138686-E1737FAD-E989-433E-B5E7-FFB7C80A0364Q41287677-D24FF223-7117-46B1-8219-E269ABEE309FQ47398548-5A0E1DB0-284D-4320-8BD5-457D8BA0096AQ47551930-424AED2A-C0A1-4865-995C-7E8DDF6CA8F9Q49900491-7BA275C4-86FA-4130-9E9B-D00566334758Q55033661-FC993892-1946-45DB-A89D-DB4B5B4EFD26
P2860
The tale of the long tail: the cytoplasmic domain of HIV-1 gp41.
description
2012 nî lūn-bûn
@nan
2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
The tale of the long tail: the cytoplasmic domain of HIV-1 gp41.
@ast
The tale of the long tail: the cytoplasmic domain of HIV-1 gp41.
@en
The tale of the long tail: the cytoplasmic domain of HIV-1 gp41.
@nl
type
label
The tale of the long tail: the cytoplasmic domain of HIV-1 gp41.
@ast
The tale of the long tail: the cytoplasmic domain of HIV-1 gp41.
@en
The tale of the long tail: the cytoplasmic domain of HIV-1 gp41.
@nl
prefLabel
The tale of the long tail: the cytoplasmic domain of HIV-1 gp41.
@ast
The tale of the long tail: the cytoplasmic domain of HIV-1 gp41.
@en
The tale of the long tail: the cytoplasmic domain of HIV-1 gp41.
@nl
P2860
P356
P1433
P1476
The tale of the long tail: the cytoplasmic domain of HIV-1 gp41
@en
P2093
Ronald C Desrosiers
P2860
P356
10.1128/JVI.02053-12
P407
P577
2012-10-17T00:00:00Z